MKI67 and glioblastoma: We then double-stained Ki67 and GFAP in C6 and N/G cells and found that all three compounds decreased Ki67-possitive proliferating cells in C6 (Figure 2E) as well as U-87MG glioblastoma cells (Figure 2F).